Accriva Diagnostics (formerly Accumetrics) is at the forefront of revolutionizing the way doctors manage the tens of millions of patients who take antiplatelet drugs to prevent heart attack, stroke and other potentially life-threatening cardiovascular events.
Accriva Diagnostics is a privately-held company based in San Diego, California. The company develops, manufactures, and markets the VerifyNow® System, a comprehensive suite of tests for the assessment of platelet response to antiplatelet therapies. The tests are fully automated and easy-to-use allowing physicians an accurate way to assess platelet response to optimize the effectiveness of antiplatelet therapies, and to guide treatment decisions in patients who may be at risk of a life threatening thrombosis event or bleeding complication.
Accriva Diagnostics aim provide patients and healthcare professionals the highest quality clinical evidence that will allow for improved management of cardiovascular disease. Through offering products and services that are of the highest quality, we will continually strive to exceed the expectations of our customers, our shareholders and our employees.